1. Academic Validation
  2. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines

TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines

  • Nat Immunol. 2021 Jul;22(7):829-838. doi: 10.1038/s41590-021-00937-x.
Min Zheng 1 Rajendra Karki 1 Evan Peter Williams 2 Dong Yang 3 Elizabeth Fitzpatrick 3 Peter Vogel 4 Colleen Beth Jonsson 2 Thirumala-Devi Kanneganti 5
Affiliations

Affiliations

  • 1 Department of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA.
  • 2 Department of Microbiology, Immunology, & Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA.
  • 3 UTHSC Regional Biocontainment Laboratory, University of Tennessee Health Science Center, Memphis, TN, USA.
  • 4 Animal Resources Center and Veterinary Pathology Core, St Jude Children's Research Hospital, Memphis, TN, USA.
  • 5 Department of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA. Thirumala-Devi.Kanneganti@StJude.org.
Abstract

The innate immune response is critical for recognizing and controlling infections through the release of cytokines and chemokines. However, severe pathology during some infections, including SARS-CoV-2, is driven by hyperactive cytokine release, or a cytokine storm. The innate sensors that activate production of proinflammatory cytokines and chemokines during COVID-19 remain poorly characterized. In the present study, we show that both TLR2 and MyD88 expression were associated with COVID-19 disease severity. Mechanistically, TLR2 and MyD88 were required for β-coronavirus-induced inflammatory responses, and TLR2-dependent signaling induced the production of proinflammatory cytokines during coronavirus Infection independent of viral entry. TLR2 sensed the SARS-CoV-2 envelope protein as its ligand. In addition, blocking TLR2 signaling in vivo provided protection against the pathogenesis of SARS-CoV-2 Infection. Overall, our study provides a critical understanding of the molecular mechanism of β-coronavirus sensing and inflammatory cytokine production, which opens new avenues for therapeutic strategies to counteract the ongoing COVID-19 pandemic.

Figures
Products